Preclinical Research
Aging and Post-Infarct Change
Aging Mouse Hearts Are Refractory to Infarct Size Reduction With Post-Conditioning

https://doi.org/10.1016/j.jacc.2007.11.070Get rights and content
Under an Elsevier user license
open archive

Objectives

Our aim was to establish whether the efficacy of post-conditioning is maintained in aging hearts.

Background

Post-conditioning, or relief of myocardial ischemia in a stuttered manner, has been shown to reduce infarct size, in part because of up-regulation of survival kinases (extracellular-signal regulated kinase [ERK] 1/2 or PI3-kinase/Akt) during the early min of reperfusion. All of these data have, however, been obtained in adult populations; the question of whether post-conditioning–induced cardioprotection is maintained in aging cohorts is unknown.

Methods

Isolated buffer-perfused hearts were obtained from 3- to 4-month-old (adult) and 20- to 24-month-old C57BL/6J mice and subjected to 30 min of ischemia. For each cohort, hearts were randomized to receive standard, abrupt (control) reperfusion, or were post-conditioned with 3 or 6 10-s cycles of stuttered reflow. Primary end points were infarct size, cardiac expression of phospho-Akt, phospho-mitogen-activated protein kinase kinase 1/2 and phospho-ERK 1/2, and expression of mitogen-activated protein kinase-phosphatase-1 (MKP-1: phosphatase purported to play a primary role in ERK dephosphorylation).

Results

In adult mouse hearts, post-conditioning significantly reduced infarct size via up-regulation of ERK (but not Akt) signaling. In contrast, in the 2-year-old cohort, post-conditioning failed to limit necrosis, possibly a consequence of the deficit in ERK phosphorylation and increased MKP-1 expression seen in old hearts. Indeed, infusion of sodium orthovanadate, a nonspecific MKP inhibitor, attenuated MKP-1 expression and restored the post-conditioned phenotype in old hearts.

Conclusions

Old mouse hearts are refractory to infarct size reduction with post-conditioning, possibly because of an age-associated increase in MKP-1 and resultant deficit in ERK phosphorylation.

Abbreviations and Acronyms

ANOVA
analysis of variance
ERK
extracellular-signal regulated kinase
LV
left ventricle/ventricular
MEK
mitogen-activated protein kinase kinase
MKP
mitogen-activated protein kinase phosphatase
PI3 kinase
phosphatidylinositol-3-kinase
STAT3
signal transducer and activator of transcription 3

Cited by (0)

Dr. Przyklenk is currently affiliated with the Cardiovascular Research Institute, Wayne State University School of Medicine, Detroit, Michigan. Supported in part by National Institutes of Health grant R01-HL63713 (Dr. Przyklenk).